Symbiotic fermented milk and triple therapy in the treatment of Helicobacter pylori

Authors

Keywords:

Helicobacter pylori, symbiotic fermented milk, probiotics.

Abstract

Introduction: Helicobacter pylori infection has a wide worldwide distribution and is related to benign and malignant gastrointestinal diseases. Although there is no ideal scheme to eradicate the bacteria, the use of probiotics and prebiotics can serve as adjunctive therapy.
Objective: To describe the clinical, endoscopic, histopathological manifestations and the eradication of Helicobacter pylori infection in patients treated with triple therapy and symbiotic fermented milk.
Method: A descriptive, cross-sectional study was carried out from January 2017 to May 2019. 30 patients with Helicobacter pylori infection (diagnosed by histopathological study and urease test) were included. The variables included were: age, sex, clinical manifestations, endoscopic and histopathological diagnosis, and eradication of the bacteria. Descriptive statistics (percentage and measures of central tendency) were used to analyze the results.
Results: There were 71 % female patients. The mean age was 48,6 ± 16,3 years; minimum age of 18 and maximum of 74 years. Dyspepsia was present in 46,6 % of patients and epigastric pain in 33,3 %. Erythematous antral, antral erythematous erythematonodular and erythematonodular gastritis occurred in 23,3% each. Moderate atrophic chronic gastritis was found in 40 % of individuals. Helicobacter pylori was eradicated in 96,7 % of patients.
Conclusions: Female sex and the fourth decade of life predominated. Dyspepsia and moderate atrophic chronic gastritis are the most frequent symptom and histopathological diagnosis, respectively. Erythematous antral, antral erythematous, and erythematonodular gastritis represent the most common endoscopic diagnoses. The eradication rate of Helicobacter pylori was high.

Downloads

Download data is not yet available.

References

1. Afsahi A, Mahmoudi H, Ebrahimi A, Aeini Z, Esmaeili D. Evaluation of the Effect of Lactobacillus planetarium Probiotics Produced from Broad Bean Seed in Prevention of Helicobacter pylori in Stomach Tissue of C57BL/6 Mice. J Cancer Sci .2018 [acceso: 19/06/2021]; 10(4):85-9. Disponible en: https://www.hilarispublisher.com/open-access/evaluation-of-the-effect-of-lactobacillus-planetarium-probioticsproduced-from-broad-bean-seed-in-prevention-of-helicobacter-pylori-1948-5956-1000524.pdf

2. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 [acceso: 19/06/2021]; 153(2): 420-29. Disponible en: https://doi.org/10.1053/j.gastro.2017.04.022

3. Piñol Jiménez F, Paniagua Estévez M, Gra Oramas B, Reyes de la Cruz M. Helicobacter pylori y lesiones endoscópicas e histológicas en mucosa gástrica de pacientes de 50 años y más. Rev Cubana Med. 2008 [acceso: 19/06/2021]; 47(2): 1-14 Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232008000200006&lng=es

4. González-Carbajal M, Martínez L, Montero TJ, Cañete R. Diagnóstico mediante histología y test de ureasa de la infección por Helicobacter pylori en el Instituto Cubano de Gastroenterología. Rev Panam Infectol. 2009 [acceso: 19/06/2021]; 11(1):7-10. Disponible en: https://www.academia.edu/23062502/Diagnóstico_mediante_histología_y-_test_de_ureasa_de_la_infección_por_Helicobacter_pylori_en_el_Instituto_-Cubano_de_Gastroenterología_Helicobacter_pylori_infections_diagnostic_by-_histology_and_ureasa_test

5. Laserna A, Barahona-Correa JE, Alba LH. Manejo de la infección por Helicobacter pylori: apreciación crítica de la literatura. Univ Med. 2018 [acceso: 19/06/2021]; 59(3): 1-10. Disponible en: http://dx.doi.org/10.11144/Javeriana.umed59-3.pylo

6. Molina-Infante J, Corti R, Doweck J, McNicholl AG, Gisbert JP. Avances recientes en el tratamiento de la infección por Helicobacter pylori. Acta Gastroenterol Latinoam. 2017 [acceso: 19/06/2021]; 47(1):75-85. Disponible en: https://www.actagastro.org/numeros-anteriores/2017/Vol-47-N1/Vol47N1-PDF15.pdf

7. Gisbert JP, Molina-Infante J. Tratamiento actual de la infección por Helicobacter pylori. Med Clin (Barc). 2017 [acceso: 19/06/2021]; 148(1):20-2. Disponible en: https://doi.org/10.1016/j.medcli.2016.10.026

8. Guarner F, Sanders ME, Eliakim R, Fedorak R, Gangl A, Garisch J, et al. Probióticos y prebióticos. WGO; 2017. [acceso: 19/06/2021]. Disponible en: https://www.worldgastroenterology.org/UserFiles/file/guidelines/probiotics-and-prebiotics-spanish-2017.pdf

9. Oliveira G, González-Molero I. Actualización de probióticos, prebióticos y simbióticos en nutrición clínica. Endocrinol Nutr. 2016 [acceso: 19/06/2021]; 63(9): 482-94. Disponible en: https://www.elsevier.es/es-revista-endocrinologia-nutricion-12-articulo-actualizacion-probioticos-prebioticos-simbioticos-nutricion-S1575092216301139

10. Eslami M, Yousefi M, Kokhaei P, Moghadas AJ, Moghadam BS, Arabkari V, et al. Are probiotics useful for therapy of Helicobacter pylori diseases? Comp Immunol Microbiol Infect Dis. 2019 [acceso: 19/06/2021]; 64:99-108. Disponible en: https://doi.org/10.1016/j.cimid.2019.02.010

11. LU M, Yu S, Deng J, Yan Q, Yang C, XiaG, et al. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-analysis of Randomized Controlled Trials. PLoS ONE. 2016 [acceso: 19/06/2021]; 11(10):1-26. Disponible en: https://doi.org/10.1371/journal.pone.0163743

12. Hernández HR. Estómago. En: Hernández HR. Endoscopia digestiva superior diagnóstica. La Habana: ECIMED; 2014. Disponible en: https://es.slideshare.net/661125/manual-de-endoscopia-digestiva-superior-diagnstica

13. Asociación Médica Mundial AMM. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. 64a Asamblea General; 2013. Fortaleza, Brasil: Asociación Médica Mundial (AMM); 2013. [acceso: 19/06/2021]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

14. Homan M, Orel R. Are probiotics useful in Helicobacter pylori eradication? Word J Gastroenterol. 2015 [acceso: 19/06/2021]; 21(37):10644-53. Disponible en: https://doi.org/10.3748/wjg.v21.i37.10644

15. Marín González AM, Zambrano Pérez RD, Uribe Echeverry PT, Arturo Arias BL, Jaramillo Arredondo MS, López Arias PA, et al. Asociación clínica, patológica y microbiológica de Helicobacter pylori en biopsias gástricas en el departamento de Caldas-Colombia. Rev. Gastroenterol. Perú. 2018 [acceso: 19/06/2021]; 38(2): 144-50. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292018000200006&lng=es

16. Khosravi Y, Dieye Y, Poh BH, Ng CG, Loke MF, Goh KL, et al. Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients. Sci World J. 2014 [acceso: 19/06/2021]; 2014:1-10. Disponible en: https://doi.org/10.1155/2014/610421

17. Martínez Leyva L, Gutiérrez Cowan B, Rodríguez Boris L, Reyes Zamora O, Varona Linares Y, Páez Suárez D. Diagnóstico de la infección por Helicobacter pylori mediante serología, histología y cultivo. Rev Cub Med Mil. 2016 [acceso: 19/06/2021]; 45(3): 344-53. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572016000300009&lng=es

18. Rodríguez JL, Carmona R. Dispepsia funcional y dispepsia asociada a infección por Helicobacter pylori: ¿son entidades con características clínicas diferentes? Rev Gastroenterol México. 2016 [acceso: 19/06/2021]; 81(3):126-33. Disponible en: http://www.revistagastroenterologiamexico.org/es-pdf-S0375090616300349

19. Alonso Soto J, Rojas Guerrero M, Díaz Rondón B, Arocha Stalella K, Manzano Carbonell T, Chao González L. Terapia clásica frente a terapia secuencial en la erradicación de la infección por Helicobacter pylori. Rev Cubana Med. 2016 [acceso: 19/06/2021]; 55(3): 211-23. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232016000300004&lng=es

20. Oliveros R, Pinilla RE, Facundo H, Sánchez R. Cáncer gástrico: una enfermedad prevenible. Estrategias para intervención en la historia natural. Rev Colomb Gastroenterol. 2019 [acceso: 19/06/2021]; 34(2):177-89. Disponible en: https://doi.org/10.22516/25007440.394

21. Vaiserman AM, Koliada AK, Marotta F. Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Res Rev. 2017 [acceso: 19/06/2021]; 35:36-45. Disponible en: https://doi.org/10.1016/j.arr.2017.01.001

22. Correa S, Cardona AF, Correa T, Correa LA, García HI, Estrada S. Prevalencia de Helicobacter pylori y características histopatológicas en biopsias gástricas de pacientes con síntomas dispépticos en un centro de referencia de Medellín. Rev Col Gastroenterol. 2016 [acceso: 19/06/2021]; 31(1):9-15. Disponible en: https://doi.org/10.22516/25007440.67

23. Latorre G, Jiménez M, Robles C, Jensen E, Ramos B, Fritzsche M, et al. Aumento de detección de lesiones gástricas premalignas mediante protocolo Sydney en comparación con biopsias no protocolizadas. Rev Gastroenterol Latinoam. 2016 [acceso: 19/06/2021]; 27(4): 207-14. Disponible en: https://gastrolat.org/DOI/PDF/10.0716/gastrolat2016n400002.pdf

24. Sobrino-Cossío S, Abdo JM, Emurac F, Galvis-García ES, Márquez ML, Mateos-Pérez G, et al. La eficacia de la imagen de banda estrecha para la detección de metaplasia intestinal en pacientes adultos con síntomas de dispepsia. Rev Gastroenterol México. 2018 [acceso: 19/06/2021]; 83(3):245-52. Disponible en: http://www.revistagastroenterologiamexico.org/en-la-eficacia-imagen-banda-estrecha-articulo-resumen-S0375090618300247

25. Chey WD, Leontiadi GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017 [acceso: 19/06/2021]; 112(2): 212-39. Disponible en: https://doi.org/10.1038/ajg.2016.563

26. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto Consensus for the Treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016 [acceso: 19/06/2021]; 151(1):51-69. Disponible en: https://doi.org/10.1053/j.gastro.2016.04.006

27. Dang Y, Reinhardt JD, Zhou X, Zhang G. The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis. PLoS ONE. 2014 [acceso: 19/06/2021]; 9(11):1-15. Disponible en: https://doi.org/10.1371/journal.pone.0111030

28. Zhang MM, Qian W, Qin YY, He J, Zhou YH. Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis. World J Gastroenterol. 2015 [acceso: 19/06/2021]; 21(14):4345-57. Disponible en: https://doi.org/10.3748/wjg.v21.i14.4345

Downloads

Published

2022-03-05

How to Cite

1.
Gil Llanes I, Barroso Márquez L, Rodríguez Martínez O, Chao González L, Samada Suárez M, Tusen Toledo Y, et al. Symbiotic fermented milk and triple therapy in the treatment of Helicobacter pylori. Rev Cubana Med Milit [Internet]. 2022 Mar. 5 [cited 2025 Jan. 10];51(1):e02201662. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1662

Issue

Vol. 51 No. 1 (2022): January - March

Section

Research Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.

Most read articles by the same author(s)

1 2 > >>